Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses.
about
Drak2 is not required for tumor surveillance and suppressionSynthesis and structure-activity relationship studies of 2-(1,3,4-oxadiazole-2(3H)-thione)-3-amino-5-arylthieno[2,3-b]pyridines as inhibitors of DRAK2.High-dose immunosuppressant alters the immunological status of New Zealand white rabbits following skin transplantation
P2860
Loss of DRAK2 signaling enhances allogeneic transplant survival by limiting effector and memory T cell responses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@ast
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@en
type
label
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@ast
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@en
prefLabel
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@ast
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@en
P2093
P2860
P1476
Loss of DRAK2 signaling enhanc ...... r and memory T cell responses.
@en
P2093
J B Hernandez
P2860
P304
P356
10.1111/J.1600-6143.2012.04056.X
P407
P577
2012-04-11T00:00:00Z